Literature DB >> 1143761

[Clinical use and action mechanism of propranolol].

O Tieri, A Polzella.   

Abstract

Propranololum reduces the intraocular tension by inhibiting the production of aqueous humour. In about 50% of all cases the medicament, given as 1% drops, proves an effective anti-glaucomatous agent. Combined with adrenaline it is particularly effective and well tolerated.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1143761     DOI： 10.1159/000307158

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN： 0030-3755            Impact factor:   3.250


  3 in total

1.  Metoprolol eye drops in the treatment of glaucoma. A double-blind single-dose trial of a beta1-adrenergic blocking drug.

Authors:  F E Ros; C L Dake; N J Nagelkerke; E L Greve
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1978-06-19

2.  Atenolol 4% eye drops and glaucoma. A double-blind short-term clinical trial of a new beta1-adrenergic blocking agent.

Authors:  F E Ros; C L Dake; L Offerhaus; E L Greve
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1977-12-31

3.  Ocular penetration of beta-adrenergic blocking agents. An experimental study with atenolol, metoprolol, timolol and propranolol.

Authors:  F E Ros; H C Innemee; P A van Zwieten
Journal:  Doc Ophthalmol       Date:  1980-04-15       Impact factor: 2.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.